Summary: The Quest for Synthetic Blood
This documentary investigates the critical global shortage of blood and the scientific race to find a synthetic substitute. With an aging population and declining birth rates, traditional blood donations are becoming insufficient. The film explores various innovative solutions, from stem cell research to “Patient Blood Management,” but highlights one particularly surprising source: the lugworm.
The Lugworm Solution
Biologist Dr. Franck Zal discovered that the hemoglobin of the lugworm (Arenicola marina) is a potential game-changer. Unlike human hemoglobin, which is contained within red blood cells, the worm’s hemoglobin floats freely and can carry 156 oxygen molecules compared to just four in humans. It is also universal, compatible with all blood types, and can be used to preserve organs for transplants significantly longer than current methods.
Stem Cells and Synthetic Alternatives
Researchers in Germany and the UK are taking a different approach by trying to breed red blood cells from stem cells. While they have successfully created mature red blood cells in the lab, the challenge remains scaling up production to meet the massive demand efficiently and cost-effectively.
Patient Blood Management
In Zurich, doctors are reducing the need for transfusions through Patient Blood Management. This involves preparing patients before surgery (e.g., treating anemia with iron supplements) and using advanced techniques during operations to minimize blood loss. This strategy has already reduced blood product usage by around 50% in some hospitals.
Final Thoughts
While a perfect, mass-producible synthetic blood substitute for long-term use is still on the horizon, innovations like lugworm hemoglobin and better blood management offer immediate hope for easing the global shortage and saving lives in emergencies and organ transplants.
Vocabulary Table
| Term | Pronunciation | Definition | Used in sentence |
|---|---|---|---|
| Hemoglobin | /ˌhiːməˈɡloʊbɪn/ | A red protein responsible for transporting oxygen in the blood of vertebrates. | The key lies in their blood, specifically in their hemoglobin. |
| Transfusion | /trænsˈfjuːʒn/ | The act of transferring donated blood or other fluid into the circulatory system of a person or animal. | A blood transfusion is a magical form of treatment. |
| Synthetic | /sɪnˈθɛtɪk/ | Made by chemical synthesis, especially to imitate a natural product. | Scientists search for a formula to manufacture this elixir synthetically. |
| Erythrocyte | /ɪˈrɪθrəˌsaɪt/ | A red blood cell that (in humans) is typically a biconcave disc without a nucleus. | Because of the red blood cells, known as erythrocytes, the body has solved a complex problem. |
| Stem Cell | /ˈstɛm sɛl/ | An undifferentiated cell of a multicellular organism which is capable of giving rise to indefinitely more cells of the same type. | Stem cells are the focus for Tanton and his team. |
| Anemia | /əˈniːmiə/ | A condition marked by a deficiency of red blood cells or of hemoglobin in the blood. | Treatment for the anemia must be set in motion before surgery. |
| Coagulate | /koʊˈæɡjʊleɪt/ | (Of a fluid, especially blood) change to a solid or semi-solid state. | The inability of the blood to coagulate sufficiently must be balanced. |
| Hemophilia | /ˌhiːməˈfɪliə/ | A medical condition in which the ability of the blood to clot is severely reduced. | From birth, he has suffered from hemophilia. |
| Antibody | /ˈæntɪbɒdi/ | A blood protein produced in response to and counteracting a specific antigen. | There are people whose antibodies reject so many different blood types. |
| Pathogen | /ˈpæθədʒən/ | A bacterium, virus, or other microorganism that can cause disease. | Health risks such as HIV, Hepatitis B, or entirely new pathogens. |
| In vitro | /ɪn ˈviːtroʊ/ | (Of a process) performed or taking place in a test tube, culture dish, or elsewhere outside a living organism. | Extracting erythrocytes from a cell culture in vitro is an outstanding achievement. |
| Universal | /ˌjuːnɪˈvɜːrsQl/ | Applicable to all cases. | Having a hemoglobin available that could work for all blood groups would be universal. |
| Bottleneck | /ˈbɒtlnɛk/ | A situation that causes delay in a process or system. | The University Hospital suffers from repeated bottlenecks in blood supply. |
| Demographics | /ˌdɛməˈɡræfɪks/ | Statistical data relating to the population and particular groups within it. | This is the most pronounced change in the demographics of the population structure. |
| Sterile | /ˈstɛraɪl/ | Free from bacteria or other living microorganisms; totally clean. | A sterile environment is needed to avoid contamination. |
Vocabulary Flashcards
While-viewing Tasks
Complete these tasks while watching the video to understand the science of synthetic blood:
Guided Notes
Fill in the key numbers and terms as you watch:
- The world faces a shortage of approximately million liters of blood.
- Donated blood can be stored for up to days.
- Lugworm hemoglobin can bind molecules of oxygen (humans bond only 4).
- Researchers in Bristol can currently only extract milliliters of blood from 30 liters of fluid.
- About % of patients coming for elective surgery are anemic.
Questions
Answer these questions based on the documentary:
- Why is the blood shortage getting worse in countries like Germany?
- What was the major “Blood Scandal” in the 1980s that shook public confidence?
- What is the main advantage of the lugworm hemoglobin “M101” for organ transplants?
- Why is “scaling up” the biggest challenge for stem-cell-based blood?
Checklist
Tick off these medical solutions as they are discussed:
- Lugworm Hemoglobin (M101)
- Stem Cell-derived Red Blood Cells
- Perfluorocarbons (milky emulsion)
- Cell Saver machines (cleaning patient’s blood)
- Hemopure (Cattle hemoglobin)
Embedded Video:
Fill in the Blanks Exercise
1. Blood can be stored well-chilled for up to days.
2. In Germany, the number of blood donors is only around percent.
3. The Lugworm is also known by its scientific name marina.
4. Hemophilia is the inability of the blood to sufficiently.
5. The Paul Ehrlich Institute is responsible for the of blood products in Germany.
6. Lugworm hemoglobin can bond molecules of oxygen.
7. Stem cells for synthetic blood research are often obtained from human marrow.
8. The Blood Type Negative is particularly sought after as it is well tolerated.
9. Researchers in Bristol can extract 5 milliliters of blood from liters of fluid.
10. Lugworm hemoglobin is being used to help preserve for transplants.
11. “Patient Blood Management” aims to reduce the need for during surgery.
12. A heart transplant organ should be out of the body for no longer than hours.
13. Synthetic blood from stem cells will be tested on humans starting in (according to the video).
14. About 30% of patients arriving for elective surgery are .
15. Every transfusion is technically a minor .
Vocabulary Quiz
Fact or Fiction Quiz
Extension Activities
Explore the frontiers of medical science with these activities:
The Lugworm Profile
Research the Lugworm (Arenicola marina). Create a biological profile (habitat, diet, anatomy) and explain why it evolved such efficient hemoglobin. Draw a diagram comparing its hemoglobin molecule to a human’s.
Easy
The Blood Scandal
Investigate the Contaminated Blood Scandal of the 1980s/90s in your country (or globally). What new regulations were put in place because of it? Write a short report on how blood safety protocols have changed.
Medium
The Ethics of Artificial Blood
Partner A is a scientist advocating for the immediate use of “Worm Blood” in emergencies to save lives. Partner B is a regulator concerned about unknown long-term side effects and antibodies. Debate: Should we fast-track approval?
Medium
Design a Blood Management Plan
Your group is in charge of a hospital with a critical blood shortage. Create a “Patient Blood Management” policy. What steps will you take before, during, and after surgery to minimize blood loss? Present your protocol.
Hard